What stock with the monopoly on ET-743 is Keith Fitz-Gerald teasing?Relatively new to the site – was wondering how to go about submitting teaser candidates, so just thought I’d ask here – please point me in the right direction, if there’s a preferred route.
I received another teaser from Keith Fitz-Gerald’s Total Wealth today, wherein he talks about a small biotech firm with a monopoly on one of the rarest resources on the planet, with the scientific name ET-743. Has anyone else seen this, and know what company he’s talking about?
Thanks,
Lou
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
Pharmamar
Oncology Pipeline: https://www.pharmamar.com/science-and-innovation/oncology-pipeline/
Could it be Stellar Biotechnology. They have been breeding Limpid (Blue Blood)
PharaMar is the company.
The two previous comments are correct Pharmamar or Pharma Mar is the company, symbol PHM.MC on the Madrid exchange. That was easy, finding out about purchasing Euros and opening accounts on foreign exchanges is proving a tougher nut to crack.
Jim – interactivebrokers.com is your solution. Best2You-Ben
Thanks Ben.
Hello Sogiam,
Have you personally invested in this Company? And do you believe it’s better to go ahead and try purchasing these Shares directly and not through Radical Technology as I understand they sell at 10/11% higher?
I totally new to Investing all together so any Help is much appreciated.
Thank you,
Jean-Paul
There are no shares from Radical Technology.
Interactive Brokers might have info.
https://www.interactivebrokers.com/inv/en/main.php
everbank can help you.
Very easy to open an account. Contact Banco Santander in Spain. They will open an account for you with passport ID and make any trade you need on the IBEX.
Impressive – thank you – I hope, over time, to learn how you guys piece it together…
I just googled who the patent holder was on this one!
Pharmamar, as of this writing, is trading at 1.99 Euro, or 2.21 USD per share. As I understand the pre-IPO offer via Fitz-Gerald, 100 shares can be bought for 245 USD, or 2.45 USD per share, which is approximately 11% more per share than if one bought the shares outright from Pharmamar, not including the $2000 subscription fee to the newsletter. If there is a good reason for me not to buy the shares directly from Pharmamar, please share your thoughts. Many thanks to all the posters and to the Gumshoe team.
I think the $2,450 subscription price may answer your question! 😉
If possible I would also like to know the name of the company that sells ET-743
I am new to the stock market. Lynn
Isn’t Phm.mc already a publicly traded company.
Paul, the pre-IPO I’m referring to pertains to NASDAQ. They are currently traded in the Spanish stock exchange, but not in the US.
Is there any additional risk to buying PharmaMar off the Spanish stock exchange now as opposed to buying pre NASDAQ ipo round lot stakes?
it is the same thing, there is not private placement
I’m new to Investing in Stocks all together. I don’t want to have a disappointing Start in this Business. So anyone that cares sharing his or her professional Opinion would be much appreciated.
The Presentation by Radical Techonology about this Cancer Wonder Drug sounded like a Lifetime Opportunity for big and quick Profits.
Anyone Experienced enough out there that has invested in PharmaMar Company and shares the same potential Earning Projections as Mr. Michael Robinson?
Thank you for any Comments you might have 🙂
Jean-Paul welcome to the Gummunity 🙂 You are ONE lucky fellow to have found stockgumshoe early in your investing journey. Travis has previously written a blog that may assist you along the way here: http://www.stockgumshoe.com/2014/11/first-steps-and-favorite-tools-for-new-investors/ HOW DO YOU FIND, LEARN ABOUT, AND KEEP ON TOP OF YOUR INVESTMENTS? I wish you success. Best2You-Ben
Hello Ben,
I do appreciate your Input. I will read the Article you
recommended.
By the way my Apologies for responding this late,
I couldn’t find this Blog again until just now.
Do you know of StockGumShoe has a I-Phone friendly
Version of this Site?
Thank you and best of Luck do you as well.
Jean-Paul Alcantara
Many in the Gummunity access stockgumshoe.com via I-phone Jean-Paul. Best2You-Ben
Thank you Ben
This is one that you should run from as fast as you can. I watched his video last night. IMO this is a big scam. Pre- IPO for $245 for 100 shares? Over 2000% profit? I would put the odds of this happening at 0.000000000001%.
I bought 2000 shares on the IBEX, Madrid Exchange, doubled my money but still not convinced this is all that Radical is saying it is. So far I am holding, its not a big investment so I can wait and see.
Several of your posters seem to be buying because they believe Keith Fitzgerald’s story. While it may be in a publisher’s interest to get it right (so you renew your subscription) he might well also be happy to keep the $2450, forget a renewal and look for new suckers. Could someone with knowledge of the science involved say if the pitch make sense please.
pitch makes perfect sense. will it work? who knows. It is biotech and there is a reason it trades in Spain at $2 a share.
The negative of buying the shares on the Spanish market is the transfer fees and conversion costs that come into play when you want to cash out — and who knows what the Spanish money will get you in dollars then?
Can you tell me what the ‘pre nasdaq ipo lot stakes are’, and how a retail investor can get in on this, that is, IF the stock is worth buying. Does anyone share Keith Fitzgerald’s opinion? I think this was from Tim:
‘buying pre NASDAQ ipo round lot stakes?’
previously discussed, you buy it on spanish exchange pre nasdaq ipo later this year
http://bigcharts.marketwatch.com/quickchart/quickchart.asp?symb=ES%3APHM&insttype=Stock
Should be an easy way to buy into this
It’s easy, but broker must be able to buy on the Spanish exchange. Be aware of the
currency exchange rate and possible higher commission. Still worth some consideration
if you can handle the risk. More info at Pharmamar.com (MSE:PHM). Good luck – I’m
there already.
On Etrade PharmaMar’s symbol is PHMMF and the current SP is $3.24.
I want to buy pharmamar ipo at nasdaq
How I can do this?
It Sounds like on that I got from Money Map Press about ET-73 in which a thimble full of this product is worth 59 million dollars.
Also following the information about the IPO for ET-73 being offered by “Money Morning” publication put out by “Money map Express”. In following the leads discovered on the Internet was able to learn the following infor. posted by Johnson and Johnson, Inc a publicley traded company, on Nov 24, 2014
Under a licensing agreement with PharmaMar, a wholly owned member of Zeltia Group, Janssen Products, LP, holds the right to develop and sell “Yondelis”(Trabectedin) globally, except in Europe, where PharmaMar SA holds the the rights. If approved in the US, Yodelis would be commercialized by Janssen Biotech, Inc, a private company and subsidary of Johnson and Johnson, Inc.
Further research tells me that this product has been approved by the FDA Dec 4, 2015. Would be interest if anyone has any additional information concerning this information.
Yes, Pharmamar is getting some royalties from J&J for Yondelis. You can see their most recent quarterly report here if you want a bit more information, I don’t have an opinion on the company personally but it’s been traded in Madrid for a while and they have been saying for perhaps a year or so that they’d like to get a US listing (which is the ambition of most biotech/pharma companies who need to raise money, since US listings are far more visible and there are far more biotech speculators and investors in the US than in smaller financial markets).
Can someone PLEASE (who knows) tell us who the company is?
John, I’m still researching for this company. As I indicated in my blog from 8/29 in would appear that Janssen Products,LP, hold the the rights to market this product in the USA under the name of Janssen Biotech, Inc. However Janssen Biotect, Inc or Janssen Products, LP, is a subsidirary of Johnson and Johnson who you know is a large organization. The only way this can happen is if Janssen has a separate agreement with Johnson and Johnson that allows them to market this product. I even tried calling Janssen Biotech and they wouldn’t tell me anything. I left a message with Investor Relation at Johnson and Johnson and have not had a returned call. At this point I don’t know if I’m chasing the right rabbit or not. All of this information I found by googleing ET-73, found a similiar designation of ET-743, which turned out to be a molecule called “Trabectdin” which led to “Yondelis” which represents the name of the product which was originally developed in Spain by a company called PharmaMar, a wholly owned member of the Zeltia Group. They have given the rights to Janssen to market this product in the USA.
Radical Technology which is the company offering this teaser also put out a teaser back in January or February which is evidenced by the blogs posted earlier this year on this website. Perhaps an email to one them might turn up some results previously discovered. I’ve been researching this off and on for several days now. I would welcome the help.
Can anyone explain if I purchase a share of the stock ( PHM.ES ) that trade in Spain Stock Exchange & a share of the stock ( PHMMF ) that trade in USA over the counter before the company IPO NASDQ offering.
How does both share of stocks ( PHM.ES & PHMMF ) convert to the share that you will be offering in upcoming IPO NASDQ offering in New York ?
Is there a process involve or automatic conversion of shares before NASDAQ IPO ?
Yes
GOD WOUL BLESS THIS COMP.